Adaptin Bio, Inc. (APTN) Operating cash flow 2023–2025
Adaptin Bio, Inc. (APTN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.8MFY2025 · since FY2023: -$81,035 → -$4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.8M | -635.9% |
| FY2024 | -$649,283 | -701.2% |
| FY2023 | -$81,035 | — |
Source: SEC XBRL filings · For reference only · Not investment advice